[Form 4] CNO Financial Group, Inc. Insider Trading Activity

Rhea-AI Filing Summary

CNO Financial Group (CNO) – Insider Form 4 filing discloses two open-market sales of common stock by Chief Information Officer Michael E. Mead under a Rule 10b5-1 trading plan adopted 27 March 2025.

• 07 July 2025: Sold 12,581 shares at a weighted-average price of $37.9656.
• 03 July 2025: Sold 12,389 shares at a weighted-average price of $38.1998.

The combined disposition totals 24,970 shares, generating proceeds of roughly $0.95 million. After the transactions, Mead’s direct beneficial ownership falls from 40,699 shares to 15,729 shares, a reduction of approximately 61 %. The Form indicates all sales were executed pursuant to the pre-arranged plan, and prices ranged between $37.66 and $38.35 per share.

There are no derivative transactions or acquisitions reported, and no indication of additional indirect holdings. While rule-based trading plans help mitigate information-asymmetry concerns, the sizable decrease in ownership by a senior executive may attract investor scrutiny, particularly if taken as a sentiment indicator ahead of upcoming earnings or strategic events.

Positive

• Sales executed under a pre-established Rule 10b5-1 plan, lowering potential insider-information risk and demonstrating compliance with best-practice governance.
• CIO retains 15,729 shares, maintaining an ongoing equity interest aligned with shareholders.

Negative

• Disposal of 24,970 shares reduces ownership by roughly 61 %, which can be interpreted as a bearish sentiment from a senior executive.
• No offsetting purchases or option exercises were reported, indicating a net decrease in insider exposure.

Insights

Securities Analyst

TL;DR Substantial insider sale (~61 % holdings) via 10b5-1 plan; modest negative sentiment but limited fundamental impact.

The disposition removes nearly two-thirds of the CIO’s stake, signalling personal monetisation rather than confidence accumulation. However, execution under a disclosed 10b5-1 plan reduces concerns around informational advantage and limits the inference that management foresees operational weakness. The aggregate dollar amount (~$0.95 M) is small relative to CNO’s market capitalisation, so immediate valuation impact is likely minimal. Investors may still perceive a modest bearish signal until upcoming results reaffirm fundamentals.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mead Michael E.

(Last) (First) (Middle)

C/O CNO FINANCIAL GROUP, INC.

11299 ILLINOIS STREET, SUITE 200

(Street)

CARMEL IN 46032

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/03/2025		S		12,389(1)	D	$38.1998(2)	28,310	D
Common Stock	07/07/2025		S		12,581(1)	D	$37.9656(3)	15,729	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on March 27, 2025.

2. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.965 per share to $38.35 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

3. Reflects the weighted average sale price. Shares were sold at prices ranging from $37.66 per share to $38.31 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

Remarks:

	Heidi M. Krings, Attorney-in-Fact	07/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CNO shares did CIO Michael E. Mead sell in July 2025?

He sold a total of 24,970 common shares across two transactions.

What prices did the CNO shares sell for?

Weighted-average prices were $38.1998 on 3 July 2025 and $37.9656 on 7 July 2025.

How many CNO shares does the CIO now own?

Post-sale, Mead directly owns 15,729 shares of CNO common stock.

Was the transaction under a Rule 10b5-1 trading plan?

Yes. The Form 4 states the shares were sold under a 10b5-1 plan adopted on 27 March 2025.

Did the filing report any derivative security activity?

No. Table II shows no derivative acquisitions or disposals for the period.